All posts tagged ross camidge

  • Dandelion

    “Weeding the garden” with radiation allows ALK+ lung cancer patients to continue crizotinib, increasing survival

    CU Cancer Center study shows that patients taking crizotinib for ALK+ non-small cell lung cancer may safely and durably use up to three courses of targeted radiation therapy to eradicate pockets of drug-resistant disease. Eliminating these pockets of resistant disease allows patients to continue treating the overall condition with crizotinib, leading to improved 2-year survival rate compared with patients forced to discontinue the drug sooner.

2327090343_cfd56b7636_b
Camidge
Pills
camidge-basket_award
Lungs.Embroidered
dandelions2
Ross Camidge, MD, PhD
CU Cancer Center Lung Team
Image: Flickr/luc.viator